Global /South Korea /Healthcare /Drug Manufacturers - Specialty & Generic /222040
chevron_leftBack
Cosmax Nbt, Inc. logo

Cosmax Nbt, Inc.

222040
KRX: 222040 Delayed
4,870KRW -1.2%
3.12 USD
As of 6 June 2026, Cosmax Nbt, Inc. has a market cap of $69.33M USD, ranking #28185 globally and #1482 in South Korea. It ranks #2548 in the Healthcare sector, and #138 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
28185
Country Rank
1482
Sector Rank
2548
Industry Rank
138
Key Stats
Market Cap
$69.33MUSD
106.27B KRW
Enterprise Value
$147.47MUSD
230.05B KRW
Revenue (TTM)
$187.55MUSD
287.48B KRW
EBITDA (TTM)
$10.57MUSD
16.49B KRW
Net Income (TTM)
-$9.81MUSD
-15.04B KRW
EBITDA Margin
5.7%
Profit Margin
-5.2%
PS Ratio
0.4
PB Ratio
2.2
EV/EBITDA
14.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jin-Hyuck Kwon open_in_new
Employees
513
Founded
2002
Website
cosmaxnbt.com.au open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.2% 3.9% 23% 51% 53% 21%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
222040
코스맥스엔비티(주)
ISIN: KR7222040008
Shares Out.:
20.555M1 Shares Float: 11.269M2
TV:
SA:
YF:
GF:
BA:
MS:
4,870 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Cosmax Nbt, Inc.

Cosmax Nbt, Inc. operates as a health functional food company in South Korea and internationally. It also provides original design and original brand manufacturing services. In addition, the company offers cosmetics, medicines, and medical supplies. It offers its products in tablets, capsules, liquid, and powder supplement form of dosages. The company serves its products through business to business, distribution companies, pharmaceutical and food companies, networks, and online channels. Cosmax Nbt, Inc. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (South Korea)
Name
Market Cap diff.
PE
$539.11M
826.36B KRW
678%
8.4
220100
$278.08M
426.25B KRW
301%
-
200130
$218.56M
335.01B KRW
215%
-
$203.29M
311.61B KRW
193%
16.3
194700
$167.22M
256.31B KRW
141%
7.4
$98.78M
151.41B KRW
42%
17.8
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
54K%
24.2
$29.56B
43K%
-
$15.86B
107.34B CNY
23K%
16.0
CIPLA
$11.12B
1.06T INR
16K%
23.4
LUPIN
$11.0B
1.05T INR
16K%
22.7
$9.1B
61.6B CNY
13K%
80.6
chevron_leftBack